MX9306467A - Formulacion novedosa. - Google Patents
Formulacion novedosa.Info
- Publication number
- MX9306467A MX9306467A MX9306467A MX9306467A MX9306467A MX 9306467 A MX9306467 A MX 9306467A MX 9306467 A MX9306467 A MX 9306467A MX 9306467 A MX9306467 A MX 9306467A MX 9306467 A MX9306467 A MX 9306467A
- Authority
- MX
- Mexico
- Prior art keywords
- novel formulation
- vacuum atmosphere
- solution
- atmosphere
- polyoxypropylene
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Packages (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un contenedor sellado farmacéuticamente aceptable el cual contiene en una atmósfera al vacío o en una atmósfera al vacío o en una atmósfera inerte una solución inyectable acuosa estéril de un copolímero de bloque de polioxipropileo/polioxietileno, estando la solución substancialmente libre de un antioxidante y estando regulada a un pH de 5.5. a 6.5.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929221883A GB9221883D0 (en) | 1992-10-19 | 1992-10-19 | Novel formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9306467A true MX9306467A (es) | 1994-05-31 |
Family
ID=10723654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9306467A MX9306467A (es) | 1992-10-19 | 1993-10-18 | Formulacion novedosa. |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0671919A1 (es) |
JP (1) | JPH08502284A (es) |
KR (1) | KR950703345A (es) |
AU (1) | AU674895B2 (es) |
BR (1) | BR9307268A (es) |
CA (1) | CA2147889A1 (es) |
CZ (1) | CZ63395A3 (es) |
GB (1) | GB9221883D0 (es) |
HU (1) | HUT75701A (es) |
IL (1) | IL107313A0 (es) |
MX (1) | MX9306467A (es) |
NO (1) | NO951462L (es) |
NZ (1) | NZ256890A (es) |
PL (1) | PL308459A1 (es) |
SI (1) | SI9300545A (es) |
SK (1) | SK44795A3 (es) |
TW (1) | TW276183B (es) |
WO (1) | WO1994008596A1 (es) |
ZA (1) | ZA937714B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009023177A1 (en) * | 2007-08-10 | 2009-02-19 | Synthrx, Inc. | Polymer therapy for the treatment of chronic microvascular diseases |
AU2014337190A1 (en) | 2013-10-16 | 2016-06-02 | Liferaft Biosciences, Inc. | Diuretic induced alterations of plasma volume |
US9757411B2 (en) | 2014-07-07 | 2017-09-12 | Aires Pharmaceuticals, Inc. | Poloxamer therapy for heart failure |
WO2016007537A1 (en) | 2014-07-07 | 2016-01-14 | Mast Therapeutics, Inc. | A poloxamer composition free of long circulating material and methods for production and uses thereof |
WO2016007542A1 (en) | 2014-07-07 | 2016-01-14 | Mast Therapeutics, Inc. | Poloxamer therapy for heart failure |
CN109432511A (zh) * | 2018-12-29 | 2019-03-08 | 常州乐奥医疗科技股份有限公司 | 一种温敏型水凝胶及其制备方法和用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3641240A (en) * | 1968-09-27 | 1972-02-08 | Wyandotte Chemicals Corp | Method for the treatment of an embolus or thrombus |
DE3234084A1 (de) * | 1982-09-14 | 1984-03-15 | B. Braun Melsungen Ag, 3508 Melsungen | Pharmazeutische zubereitungen zur behandlung von unerwuenschten verwachsungen sowie deren verwendung |
US4879109A (en) * | 1986-05-15 | 1989-11-07 | Emory University | Method for treating burns |
US4938961A (en) * | 1989-04-28 | 1990-07-03 | Geoffrey Collins | Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia |
-
1992
- 1992-10-19 GB GB929221883A patent/GB9221883D0/en active Pending
-
1993
- 1993-10-18 SI SI9300545A patent/SI9300545A/sl unknown
- 1993-10-18 IL IL107313A patent/IL107313A0/xx unknown
- 1993-10-18 WO PCT/GB1993/002141 patent/WO1994008596A1/en not_active Application Discontinuation
- 1993-10-18 HU HU9501104A patent/HUT75701A/hu unknown
- 1993-10-18 KR KR1019950701458A patent/KR950703345A/ko not_active Application Discontinuation
- 1993-10-18 BR BR9307268A patent/BR9307268A/pt not_active Application Discontinuation
- 1993-10-18 AU AU52842/93A patent/AU674895B2/en not_active Expired - Fee Related
- 1993-10-18 MX MX9306467A patent/MX9306467A/es unknown
- 1993-10-18 PL PL93308459A patent/PL308459A1/xx unknown
- 1993-10-18 JP JP6509782A patent/JPH08502284A/ja active Pending
- 1993-10-18 ZA ZA937714A patent/ZA937714B/xx unknown
- 1993-10-18 EP EP93923008A patent/EP0671919A1/en not_active Withdrawn
- 1993-10-18 TW TW082108706A patent/TW276183B/zh active
- 1993-10-18 CZ CZ95633A patent/CZ63395A3/cs unknown
- 1993-10-18 NZ NZ256890A patent/NZ256890A/en unknown
- 1993-10-18 CA CA002147889A patent/CA2147889A1/en not_active Abandoned
- 1993-10-18 SK SK447-95A patent/SK44795A3/sk unknown
-
1995
- 1995-04-18 NO NO951462A patent/NO951462L/no unknown
Also Published As
Publication number | Publication date |
---|---|
HU9501104D0 (en) | 1995-06-28 |
BR9307268A (pt) | 1999-05-11 |
TW276183B (es) | 1996-05-21 |
ZA937714B (en) | 1995-04-18 |
AU5284293A (en) | 1994-05-09 |
HUT75701A (en) | 1997-05-28 |
IL107313A0 (en) | 1994-01-25 |
SK44795A3 (en) | 1996-05-08 |
KR950703345A (ko) | 1995-09-20 |
CA2147889A1 (en) | 1994-04-28 |
JPH08502284A (ja) | 1996-03-12 |
SI9300545A (en) | 1994-06-30 |
EP0671919A1 (en) | 1995-09-20 |
NO951462L (no) | 1995-06-13 |
PL308459A1 (en) | 1995-07-24 |
GB9221883D0 (en) | 1992-12-02 |
CZ63395A3 (en) | 1995-07-12 |
AU674895B2 (en) | 1997-01-16 |
NZ256890A (en) | 1995-10-26 |
WO1994008596A1 (en) | 1994-04-28 |
NO951462D0 (no) | 1995-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU554402B2 (en) | Double sterile package | |
MD1224B2 (en) | Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B | |
ES2098029T3 (es) | Vacunas de hepatitis que contienen monofosforil lipido a 3-o-desacilado. | |
IT1232243B (it) | Composizioni farmaceutiche a base di ciclosporine | |
DE59310197D1 (de) | Lagerstabile wässrige pharmazeutische zubereitungen von g-csf | |
PL268927A1 (en) | Method of obtaining novel derivatives of benzimidazole | |
AU3855297A (en) | Pharmaceutical composition for treating papillomavirus tumours and infection | |
NZ511085A (en) | Oral pharmaceutical compositions containing buprenorphin | |
TW327602B (en) | A pharmaceutical composition of an ophthalmic suspension containing difluprednate | |
AU625083B2 (en) | Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)- en-20-yn-3-one | |
KR910021375A (ko) | 4-(디-n-프로필)아미노-6-아미노카보닐-1,3,4,5-테트라하이드로벤즈[cd]인돌의 결정형 염 | |
MX9306467A (es) | Formulacion novedosa. | |
AU4434189A (en) | An anti-human immunodeficiency virus composition | |
ZA898440B (en) | Lactamimides in the treatment of drug-resistant protozoal infections | |
AU8332791A (en) | Oral pharmaceutical compositions containing melatonin | |
DK0517160T3 (da) | Oftalmiske præparater med forlænget frigivelse | |
ATE191341T1 (de) | Tabletten mit thioctsäure bestimmter korngrösse | |
AU674379B2 (en) | Antitussive | |
IT1260469B (it) | Macchina inscatolatrice per fiale in particolare del tipo in vetro ad uso medico | |
GR3024648T3 (en) | Pharmaceutical preparation | |
NZ333656A (en) | Liquid formulation comprising less 5% w/w saturated polyglycosylated C8-10 glycerides (capryl caproyl macrogol glycerides) and a non-peptide for oro-mucosal administration | |
YU65493A (sh) | Novi preparat blok kopolimera | |
NZ236888A (en) | Antibiotic deoxymulundocandin, preparation from aspergillus sydowii culture | |
ATE126064T1 (de) | Arzneizusammensetzungen zur rektalen verabreichung enthaltend gefriergetrocknetes calcitonin. | |
TH14725EX (th) | สารสูตรผสมชนิดใหม่ |